Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Propranolol × Dermatologic × Clear all

Phase

Status

Unknown 1 Terminated 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Melanoma 1

Interventions

pembrolizumab 2 talimogene laherparepvec 1 sargramostim 1 romiplostim 1 imisopasem manganese 1 gusacitinib 1 dabrafenib 1 cobimetinib 1 Propranolol 1 Paclitaxel 1 ON 01910 1 Microscopy, Confocal 1 Magnetic Resonance Spectroscopy 1 Curettage 1 CA-4948 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01988831 2019-05-10

Efficacy of Propranolol Treatment to Prevent Melanoma Progression

University Hospital, Geneva

Phase 2 Suspended

Melanoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡